MTOR and Parkinson disease: Of note, as an activator for the mTOR pathway, increased PRR14 is detected in the CSF, serum, and plasma samples of patients with PD and relevant animal models (4, 7, 11, 12), which may result in the suppression of autophagy, accumulation of α-syn, and neuronal death (4).